Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results
February 20 2024 - 7:00AM
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced
that the company will host a conference call and webcast to discuss
its fourth quarter and full year 2023 financial results on Tuesday,
February 27, 2024, at 8:30 a.m. ET.
To access the live call by phone, please pre-register for the
call here. A live audio webcast of the event and accompanying
slides may also be accessed through the “Events and Presentations”
page of the “Investors and Media” section of the company’s website.
A replay of the webcast will be available for 90 days following the
event.
About Apellis Apellis Pharmaceuticals,
Inc. is a global biopharmaceutical company that combines courageous
science and compassion to develop life-changing therapies for some
of the most challenging diseases patients face. We ushered in the
first new class of complement medicine in 15 years and now have two
approved medicines targeting C3. These include the first-ever
therapy for geographic atrophy, a leading cause of blindness around
the world. We believe we have only begun to unlock the potential of
targeting C3 across serious retinal, rare, and neurological
diseases. For more information, please visit http://apellis.com or
follow us on Twitter and LinkedIn.
Investor Contact:Meredith
Kayameredith.kaya@apellis.com617.599.8178
Apellis Pharmaceuticals (NASDAQ:APLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Apellis Pharmaceuticals (NASDAQ:APLS)
Historical Stock Chart
From Apr 2023 to Apr 2024